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Abstract 
A parameter estimate from a meta-analysis is biased when the experiments to be combined 
are a non-random sample from the population of all experiments done on the hypothesis of 
interest. In particular, publication bias occurs when studies with significant results are more 
likely to be published than studies with non-significant results. We develop a model for the dis-
tribution of the total number of studies carried out, both published and unpublished, dependent 
on the probability of publication. We assume a selection m-odel where all studies significant 
at level a: are published, while non-significant studies are published with probability p. Using 
Metropolis simulation and Gibbs sampling techniques, we generate random samples from the 
distribution of the total number of studies and study how it changes as p varies. An application 
on lead exposure and IQ level in children is presented and the results interpreted. Comparisons 
are made with Rosenthal's fail-safe estimators. 
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1 Introduction 
Meta-analysis, a method of combining results from different experiments on the same hypothesis, 
has gained wide recognition in both the statistical and the scientific worlds in the past twenty 
years. The primary concern when carrying out a meta-analysis is the validity and reliability of the 
resulting overall conclusion, e.g., the test of an effect estimate. The most common method of finding 
experimental results to include in a meta-analysis on a specific hypothesis is through literature 
searches in relevant journals. However, journals can be unrepresentative for a number of reasons. 
Often studies with statistically non-significant results are underrepresented in the literature. For 
example, a scientist may not submit the results of a study that does not show some statistically 
significant result, or a journal editor may not accept those results, either one feeling that a result 
of "no difference" would be of little importance to the scientific community. Thus, any sample 
of studies from the published literature is typically non-random. When a meta-analysis of these 
studies is then done, an overall effect estimate could be biased towards a higher level of significance 
(Hedges, 1992). According to Bayarri and DeGroot (1986), selection bias is the distortion in an 
effect estimate resulting when a non-random sample is drawn from the population of interest. We 
concern ourselves with publication bias in particular, the selection bias resulting when studies 
statistically significant at some level a are more likely to be published than non-significant studies. 
Easterbrook, et al. (1991) carried out a retrospective study of 285 analyzed research projects 
which had been approved by the Central Oxford Research Ethics Committee between 1984 and 
1987 in order to show that publication bias does in fact exist in the medical literature. Using 
logistic regression and adjusting for relevant covariates, they found that projects with statistically 
significant results (defined to have a p-value < 0.05) were more likely to have been published 
and/or presented than those with non-significant results (odds ratio=3.56, 95% C.I.=(1.82,6.99)). 
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In addition, they noted that 43 of the 78 unpublished projects had obtained null results. Only 
8 of those 43 were written up and subsequently rejected, while 26 were never written up because 
they showed null results. Thus, it appears that publication bias here is primarily due to lack of 
submission of null results, not because of editorial rejection of submitted null results. Dickersin, 
et al. (1992) carried out a similar study using research projects that appeared on the institutional 
review board logs for the Johns Hopkins Health Institutions, including the School of Medicine, 
Hospital, Kennedy Institute, School of Nursing, and the Frances Scott Key Medical Center, and 
the School of Hygiene and Public Health. Using logistic regression and adjusting for covariates, 
they found similar results, even the conclusion that the problem lies with authors, not editors. 
A variety of methods for dealing with publication bias have been proposed. Rosenthal (1979) 
began with the fail-safe number, which calculates the number of unseen studies averaging null 
results needed to bring a meta-analytic result to some pre-specified level of significance. White 
(1982) and Glass, et al. (1981) suggest obtaining results for studies which were not published 
(through surveys of colleagues, for example, or national registries of studies) and comparing those 
results to the published results. Light and Pillemer (1984) describe a method to detect publication 
bias using a "funnel graph" of sample size vs. effect estimate. In the presence of publication 
bias, and assuming effect size is unrelated to sample size, the graph should be missing the lower 
left-hand corner of the pyramid. Berlin, Begg, and Louis (1989) introduce a method to quantify 
the information in a funnel graph by using a model relating bias to sample size under the same 
assumption. Results indicated that small trials are more prone to publication bias and that the 
bias may be substantial, especially when the trial was based on a non-randomized design. A more 
recent extension of the funnel graph idea (in Begg and Mazumdar, 1994) suggests calculating and 
then testing a rank correlation between effect estimates and their variances. A positive correlation 
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would indicate that negative studies are less likely to be published. 
The funnel graph and correlation approaches have the advantage of being based on assumptions 
which are distribution-free. Hedges (1984) meanwhile pursued truncated sampling models, where 
it was assumed that statistically non-significant results (at o:-level=0.05) do not get published. He 
found that the bias can depend on a study's sample size and effect size, and can be substantial 
for either small samples or small effects. Bayard and DeGroot (1986, 1991) explore the behavior 
of published results using an indicator function of statistical significance to weight the model's 
likelihood, and show that significant overall results obtained from published data actually can 
be strongly supportive of the null hypothesis. Iyengar and Greenhouse (1988) modify Bayard and 
DeGroot's methods slightly by not restricting the selection to this ''publish if and only if significant" 
situation. They incorporate a family of weight functions into the model's likelihood, using the 
conditional probability of reporting a study given the data as the weight, where this probability 
varied across studies. Hedges (1992) and Dear and Begg (1992) take the same approach, but modify 
these weight functions slightly, while Cleary (1996) computes estimates of the parameter of interest 
as a function of the selection parameter. Frongillo (1991) takes a Bayesian approach and uses 
two-stage hierarchical models to model variability both within and between studies. 
Historically, then, there have been three general methods of dealing with publication bias: truncated 
sampling models, invariant sampling, and source augmentation. Truncated sampling models assume 
that no non-significant studies· are published, and then, usually through simulations, determine the 
bias in the effect estimate that comes about due to the publication process. Recently this has been 
extended to include less strict selection processes. Invariant sampling methods limit the meta-
analysis to a subset of studies which come from a sampling frame independent of the publication 
process (e.g., registries of studies); extensive registries of studies, though, do not as yet exist in 
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most fields of research. Source augmentation speculates on the number of missing (unpublished) 
studies and may then adjust effect estimates accordingly (Begg and Berlin, 1988). Of the three 
methods, truncated sampling and invariant sampling often assume that the researcher has access 
to each study's effect estimates and perhaps sample variances. Reality forces us to acknowledge, 
though, that often we cannot acquire the original data from a study, sometimes not even the effect 
size estimates. Especially with older studies, it is likely that only p-values or t-values can be gleaned 
from the publication itself. This renders the use of many of the above methods impossible. On 
the contrary, source augmentation methods that have been developed so far (as well as the one we 
will explore) do not require more than p- or t-values. In spite of this advantage, we believe source 
augmentation should, whenever possible, be carried out in addition to effect size estimation. Both 
are important aspects of a meta-analysis. 
In this paper, we model the distribution of the total number of studies carried out, both seen and 
unseen, dependent on the probability of publication. This method still necessitates estimating a 
selection probability, but the distribution can then be calculated for a range of probability values, 
leading at least to a somewhat more detailed picture. Section 2 of this paper covers the derivation of 
the model and the assumptions associated with it, including the sampling methods used. Section 3 
explains the results from simulations based on the model. Section 4 presents an application of 
the Tesults to a meta-analysis on studies of lead exposure and IQ levels in children, and makes 
comparisons to the standard source augmentation method, Rosenthal's fail-safe number. Section 5 
presents our conclusions regarding the uses and limitations of this theory, and directions for further 
research. 
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2 The Approach 
2.1 The Model 
Throughout this paper, we assume that some of the assumptions necessary to conduct a meta-
analysis hold: 
i. Each of the observed studies tests the same hypothesis. 
ii. The observed studies are independent. 
The following is a usual assumption of meta-analysis that we presume does not hold: 
iii. The observed studies are a random sample from the population of all studies that have been 
carried out on this hypothesis. 
Most researchers agree that some form of selection bias, particularly publication bias, is present in 
any field, which invalidates assumption (iii.). The probability of publication, call it Q, quite likely 
varies widely from field to field, from journal to journal, and from year to year. We will impose a 
prior distribution on Q in order to account for this variability using a Beta distribution: 
11"Q(qla, b) = B (~,b) tf-1 (1- q)b-1 
where B (a, b) = r (a) r (b) ;r (a+ b), r (x) = fo00 fC- 1 exp-t dt, 0 ::::; q ::::; 1, a > 0, and b > 0. 
(Throughout this paper, we will use the symbol1r to denote probability mass or density functions.) 
The Beta distribution is very flexible, and by its parameters can vary from a bathtub shape through 
a uniform to a bell-shaped distribution. Assuming publication bias is present, Q must be dependent 
on the probability of achieving a statistically significant result, call it R. We can write: 
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Q = P [publicationlsignificant] P [significant] 
+ P [publication! non-significant] P [non-significant] 
R+p(l- R). (1) 
This structure dictates that all significant studies are published, and that the proportion p of the 
non-significant studies are published. p is a selection parameter; we will treat it as a known value. 
If p = 1, then every study will be published with probability 1; if p = 0, then a study will be 
published with the probability R that it is significant. 
When conducting a meta-analysis, one reviews the available literature and. finds all published studies 
that test the hypothesis of interest. If k such studies are found, there are still an unknown number, 
call it N - k, of studies that have actually been done, but were not published. We can thus model 
this using a negative binomial distribution: how many studies does it take until we seek successes? 
Thus the number of studies total is the random variable, N: 
7rN(nlq, k) = (: = ~)qk (1- qt-k, (2) 
where n = k, k + 1, ... , k E W, and 0 ~ q ~ 1. The distribution of N that we have here is 
conditional on an unknown value, namely q. What we are ultimately interested in, however, is the 
marginal distribution of N which is no longer dependent on the value of q. 
It is easy to find this marginal through the calculation 7rN(nlk) = f 7rN(nlq, k)7rQ(q) dq, but the 
only observed data that this incorporates is the number of published studies, k. We are ignoring 
important information relevant to publication bias if we don't take into account the number of 
significant published studies. AB we shall see in Section 2.2, incorporating this information into our 
model makes it much more difficult to find 7rN(nlk). This can be easily obtained through a Gibbs 
sampling procedure (as will be explained in Section 2.3), but the procedure requires our model's 
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full conditional specification: 
7rN(niq, O,data) and 7rQ(qln,O,data), (3) 
These are the conditional distributions of each unknown parameter of interest, where 0 denotes 
(p, a, b), the nuisance parameters. 
2.2 Derivation of the Full Conditional Specification 
We will first derive the conditional distribution of Q given N = n. Given 7rN(nlq, k) and 7rQ(qla, b), 
we can derive 7rQ(qin, k, a, b). We then have: 
( I k b) 1 k+a-1 (1 )n-k+b-1 7r Q q n, ' a, = B ( k + a, n - k + b) q - q ' 
where 0:::; q:::; 1. As stated above, we have no data in this model yet except for k. Consider the 
formulation of Q given in Equation 1. Given R =rand a pre-specified level of significance a, any 
study will be significant with probability r and non-significant with probability 1 - r. Assuming 
studies are independent (which is not too unreasonable), every study we consider, observed or 
unobserved, is the realization of a Bernoulli( r) random variable. Since larger studies will have 
more power, and hence are actually more likely to achieve statistical significance, we need to assume 
that the studies are of approximately the same size; then r will be constant across studies. The k 
observed studies in particular are thus k independent Bernoulli trials, of which a certain number 
will be "successes," where a success means statistical significance. This leads us to a Binomial(k, r) 
random variable, call it Z, which counts the number of significant studies within the observed 
studies: 
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where z = 0, 1, ... , k and 0:::; r:::; 1. (r does depend on the chosen significance level a and could 
be denoted r~.) The usual estimate of r is f = zjk, the maximum likelihood estimator (MLE). To 
then get estimates of Q in a given situation, use from Equation 1: ij = f+p(1- f)= (1-p)z/k+p, 
the MLE of Q. We can now calculate the distribution of the MLE Q, dependent on the values of 
q, k, r, and p: 
7rQ(ijlq,k,r,p) = P[(1-p) Z/k+p=ijl k,r,p] 
p [z = k(q-p) ik r P] l-p , , 
( k ) k(q-p) k lli::..el k(q-p) r 1-p (1- r) - 1-p 
1-p 
where p :::; ij :::; 1 and 0 :::; p :::; 1. Although it is not explicitly part of the equation, this density is 
dependent on q, through r and p by Equation 1. Note also that the introduction of the dependence 
on p leads the range of ij to be bounded below by p. 
Now that we have derived the distribution of the observed data ij, we should incorporate that 
information into our full conditional specification (Equation 3). Again using probability calculus: 
(q _ p)z (1 _ qt+b-z-l (q)k+a-l 
7rQ(qln, k, p, a, b, ii) = 1 +b 1 k+ 1 ' Jp (q _ p)z (1 _ qt -z- (q) a- dq (4) 
where p:::; q :::; 1 and 0 :::; p:::; 1. We now have 7rQ(qln, k, p, a, b, q) and 7rN(nlq, k). It appears as if 
the conditional distribution that we have for N is not the distribution needed for the full conditional 
specification, but note that given q, the values of p, a, b, and q are irrelevant. In other words, we 
assume that N is conditionally independent of these values. Thus, 7rN(nlq, k, p, a, b, ij) = 7rN(nlq, k) 
and we are ready to implement the Gibbs sampler. To simplify notation, and since they are assumed 
known, we will suppress the dependence on p, a, and b from now on. 
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2.3 Sampling Techniques 
The Gibbs sampler is an iterative Monte Carlo Markov chain simulation technique introduced by 
Geman and Geman (1984) and further developed by Tanner and Wong (1987) and Gelfand and 
Smith (1990). Very generally speaking, the purpose of the Gibbs sampler is to replace a difficult 
calculation (here, that of 1rN(nik)) with a sequence of easier calculations (from 1rN(nlq, k)). The 
algorithm alternately generates values from our two distributions in Equation 3 as follows: 
[0. ] Choose an arbitrary starting value qo E [0, 1]. 
[1. J Fori= 1, ... , t, generate: ni from 7rN(nlqi-1, k) 
The values of ni and the values of qi over the iterations form two Markov chains, nr, n2, ... , nt and 
qr, q2, . .. , qt, with transition kernels: 
K1(n, n') J 7rN(nlq, k)7rQ(qln', k, ij) dq 
J 7rQ(qin, k, q)7rN(nlq', k) dn. 
Under regularity conditions described in Geman and Geman (1984) and Tanner and Wong (1987), 
among many others, we have the following asymptotic results: 
nt ~ N rv 7rN(nik) as t -t 00 
qt ~ Q rv 7rQ(qik, q) as t -t 00, 
(5) 
independent of the starting value qo. Recall that our goal is to examine the distribution of N, 
the total number of studies carried out. This asymptotic result tells us that by generating a large 
enough sample n1, n2, ... , nt, we can determine any characteristic of 1rN(nik) to any degree of 
precision. 
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Before we can proceed with this algorithm, however, notice that we cannot directly generate values 
from one of our conditional distributions, that of Q. Due to the integral in the denominator, we also 
cannot find a good, well-behaving approximate distribution that has a calculable (finite) maximum 
in order to use rejection sampling. The Metropolis method (Metropolis, et al., 1953) seems to be 
the best option; this algorithm generates a value for Q from a "candidate" distribution, and accepts 
that value if it is "close enough" that it could have come from the target distribution in Equation 4. 
We begin with the following candidate distribution: 
(·'·I k A) 1 .t,z+l (1 ·'·)n+b-z-1 1fw '~-' n, 'q = B (z + £ + 1, n + b- z) '~-' - '~-' ' 
where 0 ::; '1/J ::; 1, and which matches the power of the 1- '1/J term above with the 1- q term in 
Equation 4. This is a particular Beta distribution, from which it will be easy to generate samples. 
We leave£ to be determined later; this value can be fine-tuned (for various values of a and b, for 
example) in order to even more closely approach the target distribution of Q. To correctly simulate 
Q over its range from p to 1, though, we must transform with <P = (1- p)W + p, which has the 
desired range and the following probability density function: 
(6) 
According to the Metropolis algorithm, we will generate a sample qr, q2, ... , qt from the desired 
distribution in Equation 4 by applying a decision rule as follows: given a random Uniform(O, 1) 
number, ui, and a random¢ obtained as¢= (1- p)'I/J + p from a random '1/J: 
. {1 ___!:!,p)_ g*(q;-{)} Ui < mm , h(q,_ 1 ) g•(¢ 
u· > inin {1 ___!:!,p)_g*(q,_ 1)} 
t ' h(q,_I) g•(¢) 
In our model, 
h (q) = (q _ p)z (1 _ qt+b-z-1 (q)k+a-1 
1 ( 1 )n+b+l z+l n+b-z-1 
g* (q) = B(z+l+l,n+b-z) 1-p (q- p) (1- q) 
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from Equations 4 and 6 respectively. Simplifying, we have: 
{ ( ¢ )k+a-1 (q· _ )'-} ui < min 1, Qi-1 t;I_ pp (7) 
Otherwise, the Metropolis sequence does not move and Qi = Qi-1· AB i---? oo, then, the distribution 
of Qi converges to the desired target distribution. See Metropolis, et. al (1953) for more details. 
The Gibbs technique is most easily applied here simultaneously with the Metropolis sampling as 
an iterative algorithm. First generate qo; subsequently, alternate between generating from the 
conditional distribution of N (Equation 2) and from the candidate conditional distribution of Q 
(Equation 6). More precisely, fori= 1, 2, ... , t: 
[0. ] Generate qo rv Uniform(O, 1). 
[1. ] Generate: ni 
[2. ] Test qi using the Metropolis criterion specified in Equation 7. Denote an "acceptable" value 
[3. ] Return to [1.]. 
This combined algorithm also produces two Markov chains, n11 n2, ... , nt and q1, q2, ... , Qt, each of 
which converges in distribution to the desired marginal, as in Equation 5. 
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3 Results 
3.1 Simulation Description 
The simulation algorithm described in Section 2.3 is run using the GAUSS System (Version 3.01) to 
produce 10,000 generated numbers of each of Nand Q in total, using 10 cycles of 1000 generations 
each. The number of published studies k is set first at 5 and then at 20, in order to see the effect 
of a small vs. a large meta-analysis situation. The prior parameters on Q (a and b) are each taken 
to be 5, since this gives the Beta distribution a symmetric bell-shape with somewhat thick tails. 
A variety of values for Q and p are chosen in order to see how the results varied. The value of Q 
is taken to be 1/10, 1/2, and 9/10 to cover as wide a range as possible. All valid values for p (as 
restricted by Equation 1) are used when k = 5. However, when k = 20, simulations are run for 
only 11 of the possible 33 values for p, approximately evenly spaced. In total, twenty sets of values 
are studied, nine for k = 5 and eleven for k = 20 (see Table 1). 
The parameter f is (somewhat arbitrarily) set at k +a- 1. The power of the q term then equals 
the power of the q- p term in the Metropolis criterion (see Equation 7). At the end of the ith cycle 
of 1000 generations, i = 1, 2, ... , 10, several summary values are recorded: 
• A sample average of N: Ef [N] = 1loo 2:::}~01° q~i; 
• A sample variance of N: Vari [N] = 9~ I:}~<r (q~i - Ef [NJ) 2 ; 
• An empirical distribution of N: P{ [N = n] = 10~ I:}~~ G.:::i)qfj (1- %)n-k for a range of 
values of n. 
(The superscript q indicates that the value was obtained by averaging across the corresponding 
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conditional values given the Qi/s.) In addition, at the end of the 10 cycles, the following are 
calculated: 
• An overall sample average of N: Eq [N] = 1Jioo L.:i~1 2..:}~~ q~; = 1~ L.:i~1 Ef [N]; 
• An overall sample variance: Va'rq [N] = ~ L.:i~ 1 ( Ef [N] - EJq [N]) 2 . 
The empirical distributions (frequency histograms) of N are first visually compared across the 10 
cycles to note the stability of the iterations within each set of parameter values. The graphs are 
then visually compared across values of Q and p to note the variability and trends. 
3.2 Simulation Results 
Two aspects of the results are under consideration here: 
1. Behavior of the sample expected values and standard errors across parameter values; 
ii. Behavior of the empirical distributions of N within and across parameter values. 
Table 2 shows sample expected values and sample standard errors for the nine combinations of Q 
and p when k = 5. Table 3 shows the same information for the eleven combinations chosen when 
k = 20. Within a value for Q, we can see that the spread of the distribution, as measured by the 
sample standard errors, generally increases asp decreases. The trend is more consistent for Q = 1/2 
than for Q = 9/10 in both tables. Intuitively, this trend is expected, since a smaller value for p 
indicates that fewer non-significant studies are being published. This leads to greater uncertainty 
in how many unseen studies may have been done, which leads to a distribution on the total number 
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of studies with a larger variance. The distribution on N is not bounded above, but is bounded 
below, so larger and larger values of N will have greater probabilities of occurring. The expected 
values will consequently show an increasing trend as well, as is true within every value of Q but one 
(Simulations #18- 20). (One erratic iteration of the ten in Simulation #19 enabled much larger 
values of N to occur.) The trend of increasing standard errors is more consistent within Table 2 
than within Table 3. The increase in k, or the values used for p, may have led to greater instability 
in the approximating distribution. 
When k = 5, the empirical distributions of N are very stable across the ten iterations within each 
of the nine sets of parameter values. (These graphs are not included here.) Across the values for p, 
but within a value for Q, the graphs gradually become wider and flatter asp decreases, as expected 
(see Figure 1 for an example). The change is gradual and gives the impression that the estimation 
is not extremely sensitive to the choice of p here. We can see here graphically the numerical trends 
evident in Table 2: the expected value of N increases slightly asp decreases, and the variance of 
the distribution increases slightly as p decreases. When k = 20, however, the stability decreases 
somewhat. Within a set of parameter values, the variability across the ten iterations is occasionally 
great. (These graphs are also not included.) Across these eleven sets, we see the same trends as 
when k = 5, but the changes in width and height are more dramatic, especially in Simulations #10 
- 17 (see Figure 1 for an example). Within the simulations for Q = 1/10 (#18- 20), however, the 
changes in the graphs across the values for p are very minor. Most likely this is a result of the 
very narrow range of values for p that are possible (0.0- 0.1) for these k and Q values. Outside of 
the the context of a particular meta-analysis, it is difficult to make more specific conclusions. See 
Eberly (1994) for more details, and Section 4 for an example. 
15 
4 Application: Lead Exposure and IQ in Children 
Needleman and Gatsonis (1990) details several meta-analyses of studies relating childhood lead 
exposure to IQ level. The studies were chosen from the population of all studies on lead exposure 
and children's neurobehavioral development published since 1972, as found in MEDLINE, meeting 
programs, and dissertations. Each published study is required by the authors to contain the 
following in order to be included in a meta-analysis: 
i. Use of a multiple regression analysis; 
ii. A continuous IQ level as the response variable; 
m. Lead as a main effect in the regression; 
1v. Control for non-lead covariates in the regression. 
12 studies satisfied these criteria, of which 7 measured blood lead and 5 measured tooth lead. 
Studies for which all needed information is available give the data found in Table 4 (taken directly 
from Needleman and Gatsonis, 1990, Table 5). It must be noted that neither IQ levels nor lead 
levels were necessarily measured in the same way across all studies or even within the blood or 
tooth lead groups. 
We assume a one-sided null hypothesis of a positive effect of lead on IQ, i.e., Ho : f3tead ~ 0, 
where f3tead denotes the regression coefficient. First, we carry out a simple meta-analysis (based on 
Rosenthal, 1978) to obtain an overall Z-value and p-value for the hypothesis of interest: 
Z Blood _ Lf=l Zi -3.86 - 1.67 + · · · - 1.8 5 3 
overall - ..jk = ..j7 = - · 5, 
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which gives a one-sided p-value of essentially zero. Likewise, 
zTooth = L:f=l Zi = -3- 2.23 + ... - 1.17 = -3 42 
overall Vk vg · ' 
giving a one-sided p-value of 0.0003. We have to take the t-values as approximate Z-values here; 
the sample sizes are large enough that this seems reasonable. These p-values are strong indications 
that the null hypothesis is false, but we don't yet know how representative our sample of 12 studies 
is. We run simulations as described in Section 3 in order to make an assessment of the reliability 
of our meta-analytic results. From the last column in Table 4, six of the seven observed blood 
lead studies and two of the five tooth lead studies give significant results at a= 0.05. Hence, the 
Gibbs sampler will be run first with k = 7 and f = 6/7, and second with k = 5 and f = 2/5. The 
program is run to produce 5,000 generated numbers of each of N and Q in total. By Equation 
1, then, we can choose several values for p and calculate the corresponding values for q. In order 
to capture any trend as the value of p changes, we will take p = 1/10, 1/2, and 9/10. The prior 
parameters on Q (a and b) are each taken to be 5, as before. The value for lis adjusted (up or 
down, as necessary) from its initial setting at k +a- 1 to ensure that the Metropolis sampling 
"accepts" at least 75% of the generated "candidate" values. At the end of the 5,000 cycles, the 
following are calculated: _Eq [ N] = 50~0 E~~o ~ and Va'r q [ N] = 4Jg9 Ef~9 ( k / Qi - _Eq [Nl) 2 • The 
results are shown in Table 5. 
Given the assumptions made about the prior distribution on Q, these results tell us that there 
could be about (7 - 7 =) 0 to (11 - 7 =) 4 blood lead studies on this hypothesis which were 
unseen. The researcher must now make his or her best guess at an appropriate value for p. In 
the most optimistic case, p = 9/10; most non-significant and all significant studies are published. 
In this case, we expect no unseen studies, so our sample of published studies can be considered 
entirely trustworthy. In the least optimistic case, p = 1/10 and most non-significant studies are 
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not published, whereas all significant studies are. In this case, we could have four unseen studies. 
If all of them are strongly non-significant, or significant in the opposite direction, it is possible 
that our combined p-value could be overturned. However, Needleman and Gatsonis (1990, p.677) 
makes a very good point: "Given the expense of conducting human studies of lead exposure and 
the amount of attention directed to this question, is it unlikely that this number of negative studies 
have escaped notice." Clearly knowledge of the subject matter is needed to make a judgment on 
the probable value for p. For the tooth lead studies, there could be about (5 - 5 =) 0 to (11 -
5 =) 7 unseen studies. As above, in the most optimistic case, we expect no unseen studies, and 
our meta-analysis' results seems trustworthy. In the least optimistic case, there could be more 
non-significant studies out there than studies on hand. The meta-analysis could be giving us very 
biased results. Again, though, it seems unlikely that results with strong conclusions contrary to 
published conclusions would not have been noticed. 
In cases where individual study Z-values are available, it may be helpful to compare the simulation 
results to the standard source augmentation method, Rosenthal's fail-safe number (Rosenthal, 
1979). Rosenthal's number (FS) calculates the number of unseen studies averaging null results (i.e., 
a p-value of zero or a Z-value of 0.5) needed to bring a significant overall p-value to a specified level. 
The fail-safe numbers are based on the same method of combining Z-values that was used above. 
Since those two Z-values are both significant, it makes sense to calculate Rosenthal's estimates and 
compare them with our simulation results: 
FSBlaod = [ 2:~=1 z;) 2 - kl + = [(-3.86-1.67+· .. -1.8)2 - 7] + - 66 99 (1.645 (1.645)2 - . [ , -f ~ [<-'-'<i'o';;i'117)'- 5r ~ 16.63. FSTooth = 
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Hence, 66 unseen studies giving null results are needed to overturn this combined p-value of zero 
from the blood lead studies, while 16 are needed to overturn the 0.0003 from the tooth lead studies. 
Since only 5 to 11 studies of any kind (significant or not, published or not, measuring blood or 
tooth lead levels) are expected to be out there on average, it seems highly improbable that there are 
enough unseen null studies to overturn the p-value, no matter the value of p. Taken in concert, our 
results and the fail-safe numbers offer reassurance that the meta-analyses are reliable. Rosenthal 
(1979) offers his own guidelines on what an "unlikely" number of unseen studies might be. He 
suggests that some :fields may consider 100 or 500 unseen studies plausible, whereas other fields 
may deem only 10 or 20 unlikely. Rosenthal's recommendation is to consider 5k + 10 the level at 
which the number. of unseen studies becomes implausible. The 5k suggests that it is unlikely that 
there are more than 5 times as many studies :filed away as there are on hand, while 10 sets the 
minimum number of studies at 15 when k = 1. In this example, the cutoffs would be 45 and 35 for 
the blood and tooth studies, respectively. 
As a caution, the p-values calculated in Equation 4 above are based on what may or may not 
be a good estimate of the overall Z-values. One must always keep in mind that there are many 
other ways to calculate an overall p-value, ones that, for example, take sample sizes or sample 
variances into account (see Rosenthal, 1978). Some of those methods could give non-significant 
overall results, in which case any consideration of F S is nonintuitive. In addition, since this is a 
one-sided hypothesis testing situation, the researcher must consider the possibility of unpublished 
studies that are significant in the opposite direction. Rosenthal's estimates are a useful (and possibly 
reassuring) comparison to make when the data are available to calculate them. However, they are 
strictly ad hoc estimates and the statistical properties associated with them are not known; caution 
should be used in interpreting their results. 
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5 Conclusions 
We have derived a method for approximating the total number of studies done on a particular 
hypothesis, given a selection probability (p), a distribution of the probability of publication ( Q), 
and a meta-analysis of k available studies. The theory is complex only in that it must adapt to 
circumvent practical computational difficulties (i.e., Metropolis simulation and Gibbs sampling). 
One drawback of this theory, of course, is that the prior distribution on Q must be specified. Very 
few researchers will be able to choose parameter values for the Beta prior distribution with any 
degree of assuredness. This distribution can take on almost any form for various values of a and b, 
and it is unclear how those choices influence the results of the simulations. Further investigation 
should be done regarding the effect of varying a and b on the stability of the simulations and on the 
precision of the approximations. Reassuringly, though, research in Bayesian statistics has shown 
that posterior distributions can be robust to the choice of the prior distributions. See, for example, 
Berger (1993). Another potential problem lies in the violations of assumptions. It is conceivable 
that the probability of publication is not constant across studies. In situations where a great deal 
of funding is allocated for large-scale nationwide clinical trials, for example, it is almost a certainty 
that these results will be published, significant or not. As a related issue, the biggest criticism of 
the fail-safe numbers is that they fail to distinguish between studies which are significant due to a 
large effect size, and studies which are significant due to a large sample size. Our method sidesteps 
this criticism by requiring that all studies considered are roughly of the same size. In practice, 
however, this assumption is not likely to be satisfied. 
Given the simulation program, these methods are easy to implement and easy to interpret. An 
obstacle to using this method in a specific application is that a value (or possibly values) for p 
must be chosen. A researcher must have a good familiarity with both the publication process and 
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the activities of other researchers in his or her field to be able to give a reliable estimate. We 
recommend, therefore, that the simulations always be run for a range of values for p. Hopefully, 
from personal experience, this range can at least be limited to only a small portion of the interval 
[0, 1]. The application of this theory would be much improved if a method for estimating p is 
developed. Another disadvantage is that any application of this theory can only start from a 
count of the number of significant studies (i.e., to calculate z/k) not from individual p-values nor 
Z-values. It seems there is a loss of information at some level here. Sample sizes and sample 
variances from the studies under consideration do not affect this procedure, when ideally it seems 
they should. The next step is perhaps to consider a model that depends not only on p, but also on 
other relevant covariates. Either p could be modeled deterministically, by choosing some function 
of the covariates, or a prior distribution for p could be chosen. A further and perhaps more realistic 
generalization of another aspect of the model would be to let Q = 8R + p(1 - R), so that not all 
significant studies are assumed published. 
Using a range of values for p and the Gibbs/Metropolis procedure, a reasonable picture of the 
number of unseen studies can be formed for a specific meta-analysis application. Using Rosenthal's 
fail-safe estimates, we can calculate a second indication of the reliability of a significant overall 
p-value. Combining the two procedures, we can make the following statements: if Rosenthal's 
estimates give numbers which are too large to be likely under the distribution for N, then a 
meta-analysis' conclusions can be considered reliable. If Rosenthal's estimates give numbers which 
are small enough to be likely to occur, then the meta-analysis' results are clearly questionable. 
Alternatively, a researcher with a good knowledge of his or her field can make a judgment based 
on the simulated distributions of N without reference to Rosenthal's estimates. 
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7 Tables and Figures 
Table 1: Parameter values by Simulation 
k=5 k =20 
Simulation Q p r = z/k Simulation Q p r = zjk 
1 0.9 0.900 0.0 10 0.9 0.900 0.00 
2 0.875 0.2 11 0.867 0.25 
3 0.833 0.4 12 0.800 0.50 
4 0.750 0.6 13 0.600 0.75 
5 0.500 0.8 14 0.000 0.90 
6 0.5 0.500 0.0 15 0.5 0.500 0.00 
7 0.375 0.2 16 0.333 0.25 
8 0.167 0.4 17 0.000 0.50 
9 0.1 0.100 0.0 18 0.1 0.100 0.00 
19 0.053 0.05 
20 0.000 0.10 
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Table 2: Expected values and standard errors when k = 5 
Simulation Q p j;q [N] (SE7J.[N]) 
1 0.9 0.900 5.43 (0.04) 
2 0.875 5.49 (0.04) 
3 0.833 5.60 (0.04) 
4 0.750 5.85 (0.08) 
5 0.500 6.64 (0.13) 
6 0.5 0.500 8.17 (0.26) 
7 0.375 9.04 (0.39) 
8 0.167 10.73 (1.47) 
9 0.1 0.100 16.72 (3.00) 
Table 3: Expected values and standard errors when k = 20 
Simulation Q p _Eq[N] (§E-q[N]) 
10 0.9 0.900 21.50 (0.06) 
11 0.867 21.73 (0.06) 
12 0.800 22.18 (0.20) 
13 0.600 23.24 (0.55) 
14 0.000 26.45 (0.19) 
15 0.5 0.500 32.08 (0.65) 
16 0.333 37.41 (1.60) 
17 0.000 41.35 (0.70) 
18 0.1 0.100 85.42 (4.82) 
19 0.053 103.00 (19.67) 
20 0.000 96.88 (2.78) 
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Figure 1: Simulated distributions of N 
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Table 4: Lead Coefficients for Full-scale IQ Scores 
Study Regression Standard t-value Sample One-sided 
coefficient error size p-value 
Blood Lead Studies 
Hatzakis, et al. -0.27 o.o7a -3.86a 509 0.0001 
Hawk, et al. -0.25 0.15 -1.67 75 0.05 
Schroeder, et al. -0.2 o.o7a -2.78 104 0.003 
Fulton, et al. b -3.7 1.37 -2.77 501 0.003 
Yule, et al. b -8.08 4.63 -1.75 129 0.04 
Lansdown, et al. b 2.15 4.48a 0.48 86 0.68 
Emhart, et al. NAC NA -1.8a 80 0.04 
Tooth Lead Studies 
Needleman, et al. -0.21 0.07 -3 218 0.001 
Hansen, et al . . -4.27. 1.91 -2.23d 156 0.01 
Winneke, et al. -0.13 4.66 -0.03d 115 0.49 
Pocock, et al. b -0.77 0.63 -1.22 388 0.11 
Fergusson, et al. b -1.46 1.25 -1.17 724 0.12 
aEstimated from data in article. 
6Used log transformation. 
cNot available. 
dObtained from the author. 
Table 5: Expected values and standard errors 
Simulation p q Eq [N] (§Ff [N]) 
Blood Lead Studies: k = 7 and f = 6/7 
1 0.1 0.87 10.69 (1.87) 
2 0.5 0.93 8.94 (0) 
3 0.9 0.99 7.30 (0) 
Tooth Lead Studies: k = 5 and f = 2/5 
4 0.1 0.46 10.97 (0.01) 
5 0.5 0.70 8.03 (0) 
6 0.9 0.94 5.43 (0) 
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